The pharma chain giant recently engaged strategic advisors about possibly breaking off its insurance and retail business.

Kezar Life Sciences halted its PALIZADE Phase 2b lupus nephritis trial due to fatal adverse events. Meanwhile, its PORTOLA Phase 2a autoimmune hepatitis trial progresses, with topline data expected in ...

Shares of Navratna PSU Mazagon Dock Shipbuilders surged nearly 10 per cent in today’s trading session so far. As per BSE ...

General Motors has officially become America's second-best-selling EV maker behind Tesla, pushing Hyundai Motor Group into ...

Rights Apr 13, 2023 Apr 14, 2023 Dec 09, 2022 Rights ratio: 10 share for every 211 held at a price of Rs 140.0 Rights Dec 31, 2021 Jan 03, 2022 Jul 20, 2021 Rights ratio: 1 share for every 13 held at ...

Bajaj Auto share price has seen a sharp fall recently as the auto stock plunged over 13% in one month. However, Bajaj Auto ...

Reliance Industries (RIL) has set the record date for its 1:1 bonus share issue. Post-issue, RIL's authorized share capital ...

As previously announced, official update support for Windows 10 will end on Oct. 14, 2025. The OS has long since stopped ...

China’s central bank has kicked off a specialized re-lending facility for listed companies and major shareholders to buy back ...

Meanwhile, Ian McKellen embraced his inner 365 party-girl, The Rainbow Dads got a big NFL moment, Giorgio Armani spilled some ...

With the win, the Rebels clinched at least a tie for the region championship. Central-Florence (6-2, 4-2) tied for second ...

Mid-America Apartment Communities currently trades at a compelling level of about 19.5 times its adjusted FFO, and at current ...